{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T07:20:11Z","timestamp":1767856811259,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["M23008"],"award-info":[{"award-number":["M23008"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park","doi-asserted-by":"publisher","award":["Z211100002521021"],"award-info":[{"award-number":["Z211100002521021"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFE0207300"],"award-info":[{"award-number":["2018YFE0207300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015286","name":"Hebei Provincial Key Research Projects","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015286","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virologica Sinica"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.virs.2023.07.005","type":"journal-article","created":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T03:50:51Z","timestamp":1689997851000},"page":"723-734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Inactivated SARS-CoV-2 booster vaccine enhanced immune responses in patients with chronic liver diseases"],"prefix":"10.1016","volume":"38","author":[{"given":"Yongmei","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoting","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenfang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haolong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongliang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linlin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingli","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haojie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8835-6199","authenticated-orcid":false,"given":"Erhei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8267-0985","authenticated-orcid":false,"given":"Yongzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virs.2023.07.005_bib1","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3390\/vaccines10030354","article-title":"Humoral and cellular immune responses of solid organ transplant patients on belatacept to three doses of mRNA-based anti-SARS-CoV-2 vaccine","volume":"10","author":"Abravanel","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virs.2023.07.005_bib2","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.cgh.2021.12.022","article-title":"Safety and immunogenicity of SARS-CoV-2 vaccines in patients with chronic liver diseases (CHESS-NMCID 2101): a multicenter study","volume":"20","author":"Ai","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.virs.2023.07.005_bib3","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41575-021-00520-7","article-title":"Cirrhosis-associated immune dysfunction","volume":"19","author":"Albillos","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.virs.2023.07.005_bib4","article-title":"Impaired SARS-CoV-2-specific T-cell reactivity in patients with cirrhosis following mRNA COVID-19 vaccination","volume":"4","author":"Al-Dury","year":"2022","journal-title":"JHEP Rep."},{"key":"10.1016\/j.virs.2023.07.005_bib5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3390\/v14020207","article-title":"Antibody responses after SARS-CoV-2 vaccination in patients with liver diseases","volume":"14","author":"Bakasis","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.virs.2023.07.005_bib6","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa2114255","article-title":"Protection of BNT162b2 vaccine booster against covid-19 in Israel","volume":"385","author":"Bar-On","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.virs.2023.07.005_bib7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2022.02.032","article-title":"T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma","volume":"77","author":"Barsch","year":"2022","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.virs.2023.07.005_bib8","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1038\/s41467-022-30162-5","article-title":"Comparative analysis of COVID-19 vaccine responses and third booster dose-induced neutralizing antibodies against Delta and Omicron variants","volume":"13","author":"Belik","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virs.2023.07.005_bib9","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jhep.2021.04.003","article-title":"Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: causality or casualty?","volume":"75","author":"Bril","year":"2021","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.virs.2023.07.005_bib10","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMoa2208343","article-title":"A\u00a0bivalent omicron-containing booster vaccine against covid-19","volume":"387","author":"Chalkias","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.virs.2023.07.005_bib11","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1056\/NEJMoa2114114","article-title":"Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar","volume":"385","author":"Chemaitelly","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.virs.2023.07.005_bib12","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41392-022-01032-9","article-title":"Waning humoral immune responses to inactivated SARS-CoV-2 vaccines in patients with severe liver disease","volume":"7","author":"Chen","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.virs.2023.07.005_bib13","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1007\/s10620-022-07504-w","article-title":"Autoimmune hepatitis-like syndrome following COVID-19 vaccination: a systematic review of the literature","volume":"67","author":"Chow","year":"2022","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.virs.2023.07.005_bib14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41586-021-03739-1","article-title":"Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b","volume":"596","author":"Collier","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.virs.2023.07.005_bib16","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jhep.2021.01.032","article-title":"EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipient","volume":"74","author":"Cornberg","year":"2021","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.virs.2023.07.005_bib18","doi-asserted-by":"crossref","first-page":"l6015","DOI":"10.1126\/sciadv.abl6015","article-title":"SARS-CoV-2 receptor binding domain displayed on HBsAg virus-like particles elicits protective immunity in macaques","volume":"8","author":"Dalvie","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.virs.2023.07.005_bib19","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jhep.2022.03.042","article-title":"A\u00a0third dose of the BNT162b2 mRNA vaccine significantly improves immune responses among liver transplant recipients","volume":"77","author":"Davidov","year":"2022","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.virs.2023.07.005_bib20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ueg2.12218","article-title":"SARS-CoV-2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease","volume":"10","author":"Duengelhoef","year":"2022","journal-title":"United Eur. Gastroenterol. J."},{"key":"10.1016\/j.virs.2023.07.005_bib21","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/hep.32572","article-title":"Liver injury after SARS-CoV-2 vaccination: features of immune-mediated hepatitis, role of corticosteroid therapy and outcome","volume":"76","author":"Efe","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.virs.2023.07.005_bib22","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/hep.31751","article-title":"American association for the study of liver diseases expert panel consensus statement: vaccines to prevent coronavirus disease 2019 infection in patients with liver disease","volume":"74","author":"Fix","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.virs.2023.07.005_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.abc1932","article-title":"Development of an inactivated vaccine candidate for SARS-CoV-2","volume":"369","author":"Gao","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.virs.2023.07.005_bib24","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.3390\/vaccines10081281","article-title":"Effectiveness of booster dose of anti SARS-CoV-2 BNT162b2 in cirrhosis: longitudinal evaluation of humoral and cellular response","volume":"10","author":"Giambra","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virs.2023.07.005_bib25","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.cell.2022.04.009","article-title":"Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine","volume":"185","author":"Goel","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.virs.2023.07.005_bib26","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1056\/NEJMoa2114228","article-title":"Waning immunity after the BNT162b2 vaccine in Israel","volume":"385","author":"Goldberg","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.virs.2023.07.005_bib27","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1056\/NEJMc2206576","article-title":"Neutralization escape by SARS-CoV-2 omicron subvariants BA.2.12.1, BA.4, and BA.5","volume":"387","author":"Hachmann","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.virs.2023.07.005_bib28","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12859-021-04045-3","article-title":"In silico comparative study of SARS-CoV-2 proteins and antigenic proteins in BCG, OPV, MMR and other vaccines: evidence of a possible putative protective effect","volume":"22","author":"Haddad-Boubaker","year":"2021","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.virs.2023.07.005_bib29","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/liv.15173","article-title":"Safety and antibody response to inactivated COVID-19 vaccine in patients with chronic hepatitis B virus infection","volume":"42","author":"He","year":"2022","journal-title":"Liver Int."},{"key":"10.1016\/j.virs.2023.07.005_bib30","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.jhep.2022.07.036","article-title":"Third dose of COVID-19 mRNA vaccine appears to overcome vaccine hyporesponsiveness in patients with cirrhosis","volume":"77","author":"John","year":"2022","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.virs.2023.07.005_bib31","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.00561-21","article-title":"Age-dependent reduction in neutralization against alpha and beta variants of BNT162b2 SARS-CoV-2 vaccine-induced immunity","volume":"9","author":"Kawasuji","year":"2021","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.virs.2023.07.005_bib32","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1056\/NEJMoa2114583","article-title":"Waning immune humoral response to BNT162b2 covid-19 vaccine over 6 months","volume":"385","author":"Levin","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.virs.2023.07.005_bib33","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.3390\/pathogens11121531","article-title":"Progress of the COVID-19: persistence, effectiveness, and immune escape of the neutralizing antibody in convalescent serum","volume":"11","author":"Liang","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.virs.2023.07.005_bib34","article-title":"A\u00a0third dose of an inactivated vaccine dramatically increased the levels and decay times of anti-SARS-CoV-2 antibodies, but disappointingly declined again: a prospective, longitudinal, cohort study at 18 serial time points over 368 days","volume":"13","author":"Liang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virs.2023.07.005_bib35","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s40249-021-00915-3","article-title":"Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis","volume":"10","author":"Liu","year":"2021","journal-title":"Infect. Dis. Pov."},{"key":"10.1016\/j.virs.2023.07.005_bib36","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.dld.2022.03.014","article-title":"Clinical update on risks and efficacy of anti-SARS-CoV-2 vaccines in patients with autoimmune hepatitis and summary of reports on post-vaccination liver injury","volume":"54","author":"Lleo","year":"2022","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.virs.2023.07.005_bib37","article-title":"SARS-CoV-2 variants, vaccines, and host immunity","volume":"12","author":"Mistry","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virs.2023.07.005_bib39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000521229","article-title":"Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia: a serologic and cellular study","volume":"67","author":"Molica","year":"2022","journal-title":"Chemotherapy"},{"key":"10.1016\/j.virs.2023.07.005_bib40","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/s41564-022-01163-3","article-title":"Neutralizing antibody activity against 21 SARS-CoV-2 variants in older adults vaccinated with BNT162b2","volume":"7","author":"Newman","year":"2022","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.virs.2023.07.005_bib41","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/hep.32156","article-title":"Letter to the editor: autoimmune hepatitis after COVID-19 vaccination: a rare adverse effect?","volume":"75","author":"Palla","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.virs.2023.07.005_bib42","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cgh.2021.09.003","article-title":"SARS-CoV2-specific humoral and T-cell immune response after second vaccination in liver cirrhosis and transplant patients","volume":"20","author":"Ruether","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.virs.2023.07.005_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2381","article-title":"Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: implications for immune escape and transmission","volume":"32","author":"Shrestha","year":"2022","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.virs.2023.07.005_bib44","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.jhep.2021.08.008","article-title":"Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases","volume":"75","author":"Thuluvath","year":"2021","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.virs.2023.07.005_bib45","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1016\/S2213-2600(21)00456-2","article-title":"Long-term immunogenicity of BNT162b2 vaccination in older people and younger health-care workers","volume":"9","author":"Tober-Lau","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.virs.2023.07.005_bib46","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3390\/vaccines11020452","article-title":"Efficacy, safety and immunogenicity of anti-SARS-CoV-2 vaccines in patients with cirrhosis: a narrative review","volume":"11","author":"Toutoudaki","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virs.2023.07.005_bib47","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.cell.2022.06.005","article-title":"Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum","volume":"185","author":"Tuekprakhon","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.virs.2023.07.005_bib48","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s12072-022-10332-9","article-title":"Safety and immunogenicity of SARS-CoV-2 vaccines in Chinese patients with cirrhosis: a prospective multicenter study","volume":"16","author":"Wang","year":"2022","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.virs.2023.07.005_bib49","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1038\/s41423-021-00795-5","article-title":"Safety and immunogenicity of a SARS-CoV-2 inactivated vaccine in patients with chronic hepatitis B virus infection","volume":"18","author":"Xiang","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.virs.2023.07.005_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.786554","article-title":"Response and duration of serum anti-SARS-CoV-2 antibodies after inactivated vaccination within 160 days","volume":"12","author":"Xu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virs.2023.07.005_bib51","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/s41422-020-0366-x","article-title":"Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patients","volume":"30","author":"Zhang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.virs.2023.07.005_bib52","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41421-023-00518-2","article-title":"Long-term and effective neutralization against omicron sublineages elicited by four platform COVID-19 vaccines as a booster dose","volume":"9","author":"Zhang","year":"2023","journal-title":"Cell Discov."}],"container-title":["Virologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1995820X23000858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1995820X23000858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T19:20:09Z","timestamp":1761852009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1995820X23000858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S1995820X23000858"],"URL":"https:\/\/doi.org\/10.1016\/j.virs.2023.07.005","relation":{},"ISSN":["1995-820X"],"issn-type":[{"value":"1995-820X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inactivated SARS-CoV-2 booster vaccine enhanced immune responses in patients with chronic liver diseases","name":"articletitle","label":"Article Title"},{"value":"Virologica Sinica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virs.2023.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}